Standardised surveillance of Clostridium Difficile Infection in European acute care hospitals: A pilot study, 2013

Eurosurveillance

Volumn 21, Issue 29, 2016, Pages

  van Dorp, Sofie M ^a   Kinross, P ^b   Gastmeier, P ^c   Behnke, M ^c   Kola, A ^c   Delmee M ^d   Pavelkovich, A ^e   Mentula, S ^f   Barbut, F ^g,h   Hajdu, A ⁱ   Ingebretsen, A ^j   Pituch, H ^k   Macovei, I S ^l   Jovanovic M ^m   Wiuff, C ⁿ   Schmid, D ^o   Olsen, K E ^p   Wilcox, M H ^q,r   Suetens, C ^b   Kuijper, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITY OF TARTU   (Estonia)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g SORBONNE UNIVERSITÉ   (France)

^h HÔPITAL SAINT ANTOINE   (France)

ⁱ NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^j OSLO UNIVERSITY HOSPITAL   (Norway)

^k MEDICAL UNIVERSITY OF WARSAW   (Poland)

^l CANTACUZINO INSTITUTE   (Romania)

^m CLINICAL CENTER OF SERBIA   (Serbia)

ⁿ HEALTH PROTECTION SCOTLAND   (United Kingdom)

^o AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^p STATENS SERUM INSTITUT   (Denmark)

^q LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^r UNIVERSITY OF LEEDS   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; MOXIFLOXACIN; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; FEMALE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; INCIDENCE; INFECTION RATE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PILOT STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; QUESTIONNAIRE; VERY ELDERLY; WORKLOAD; ADOLESCENT; ADULT; CLOSTRIDIUM INFECTIONS; EUROPE; GENETICS; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; LABORATORY TEST; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; RIBOTYPING; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; RIBOTYPING; YOUNG ADULT;

EID: 85015142965     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.29.30293     Document Type: Article

References (34)

1. Kuijper EJ, Coignard B, Tüll P, ESCMID Study Group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12 Suppl 6:2-18. CLM1580 [pii]; DOI:10.1111/j.1469-0691.2006.01580.x [doi]. PMID: 16965399
2. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63-73.S0140-6736(10)61266-4 [pii]; DOI: 10.1016/S0140-6736(10)61266-4 [doi]. PMID: 21084111
3. Knetsch CW, Lawley TD, Hensgens MP, Corver J, Wilcox MW, Kuijper EJ. Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill. 2013;18(4):pii=20381. PMID: 23369393
4. Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill. 2009;14(45): pii=19402. PMID: 19941791
5. Viseur N, Lambert M, Delmée M, Van Broeck J, Catry B. Nosocomial and non-nosocomial Clostridium difficile infections in hospitalised patients in Belgium: compulsory surveillance data from 2008 to 2010. Euro Surveill. 2011;16(43):pii=20000. PMID: 22085603
6. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotypingbased surveillance scheme in England. Clin Infect Dis. 2012;55(8):1056-63. cis614 [pii];DOI: 10.1093/cid/cis614 [doi]. PMID: 22784871
7. Kanerva M, Mentula S, Virolainen-Julkunen A, Kärki T, Möttönen T, Lyytikäinen O, et al. Reduction in Clostridium difficile infections in Finland, 2008-2010. J Hosp Infect. 2013;83(2):127-31. S0195-6701(12)00343-X [pii]; DOI: 10.1016/j.jhin.2012.09.021 [doi]. PMID: 23201398
8. Eckert C, Coignard B, Hebert M, Tarnaud C, Tessier C, Lemire A, et al. Clinical and microbiological features of Clostridium difficile infections in France: the ICD-RAISIN 2009 national survey. MedMal Infect. 2013;43(2):67-74. S0399-077X(13)00008-5 [pii]; DOI: 10.1016/j.medmal.2013.01.004 [doi]. PMID: 23498135
9. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. 2011-2012. Stockholm: ECDC; 2013. Available from: http://www.ecdc.europa.eu/en/publications/Publications/healthcareassociated-infections-antimicrobial-use-PPS.pdf
10. Obuch-Woszczatyński P, Lachowicz D, Schneider A, Mól A, Pawłowska J, Ożdżeńska-Milke E, et al. Occurrence of Clostridium difficile PCR-ribotype 027 and it’s closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010. Anaerobe. 2014;28:13-7. S1075-9964(14)00039-0 [pii]; DOI:10.1016/j.anaerobe.2014.04.007 [doi]. PMID: 24799338
11. Popescu GA, Florea D, Rafila A. Clostridium difficile is emerging in Romania: a story of 027 ribotype and excessive antibiotic consumption. J Gastrointestin Liver Dis. 2014;23(3):342-3. 21 [pii]. Available from: http://www.jgld.ro/2014/3/21.pdf PMID: 25267968.
12. Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14(12):1208-19. DOI: 10.1016/S1473-3099(14)70991-0. PMID: 25455988
13. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcareassociated Clostridium difficile. Nat Genet. 2013;45(1):109-13. ng.2478 [pii]; DOI: 10.1038/ng.2478 [doi]. PMID: 23222960
14. European Clostridium difficile Infection Surveillance Network (ECDIS-Net). Pilot surveillance protocol version 1.2. Berlin: ECDIS-Net; May 2013. Available from http://www.ecdis-pilot.eu/fileadmin/ecdis/downloads/v1.2/ECDIS-net_Pilot_Surveillance:Protocol_Version_1.2.pdf
15. McCabe WR. Gram-negative bacteremia. Adv Intern Med. 1974;19:135-58. PMID: 4592709PMID: 4592709
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-29. DOI: 10.1097/00003246-198510000-00009. PMID: 3928249
17. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28(2):140-5. ICHE2006386 [pii]; DOI: 10.1086/511798 [doi]. PMID: 17265394
18. van Dorp SM, Notermans DW, Alblas J, Gastmeier P, Mentula S, Nagy E, et al. Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. Euro Surveill. 2016;21(29):30292. DOI: 10.2807/1560-7917.ES.2016.21.29.30292
19. Regions in the European Union. Nomenclature of territorial units for statistics NUTS 2013/EU-28. Luxembourg: Publications Office of the European Union; 2015. Available from: http://ec.europa.eu/eurostat/documents/3859598/6948381/KS-GQ-14-006-EN-N.pdf/b9ba3339-b121-4775-9991-d88e807628e3
20. Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, van der Vorm ER, Kuijper EJ. Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect. 2007;13(11):1058-64. CLM1793 [pii]; DOI: 10.1111/j.1469-0691.2007.01793.x [doi]. PMID:17922780
21. Bidet P, Lalande V, Salauze B, Burghoffer B, Avesani V, Delmée M, et al. Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol. 2000;38(7):2484-7. PMID:10878030
22. Persson S, Torpdahl M, Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect. 2008;14(11):1057-64. CLM2092 [pii]; DOI: 10.1111/j.1469-0691.2008.02092.x [doi]. PMID: 19040478
23. Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. 8th ed. Wayne, PA: CLSI; 2012.
24. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0, 2014. [Accessed 25 Jan 2015]. Available from: http://www.eucast.org/clinical_breakpoints/
25. United States Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. Atlanta, GA: CDC; 23 Apr 2013. Accessed 25 Jan 25 2015. Available from: http://www.cdc.gov/drugresistance/threatreport-2013/pdf/ar-threats-2013-508.pdf
26. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198-208. DOI: 10.1056/NEJMoa1306801 PMID: 24670166
27. European Centre for Disease Prevention and Control (ECDC). European surveillance of Clostridium difficile infections. Surveillance protocol version 2.2. Stockholm: ECDC; 2015. Available from: http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90andID=1402
28. Pituch H, Obuch-Woszczatyński P, Lachowicz D, Wultańska D, Karpiński P, Młynarczyk G, et al. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Euro Surveill. 2015;20(38):pii=30025. DOI: 10.2807/1560-7917.ES.2015.20.38.30025 [doi];30025 [pii].PMID: 26536049
29. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, Shine B, et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis. 2013;56(11):1589-600. cit127 [pii]; DOI: 10.1093/cid/cit127 [doi]. PMID: 23463640
30. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect. 2009;15(12):1053-66. CLM3098 [pii];DOI: 10.1111/j.1469-0691.2009.03098.x [doi]. PMID: 19929972
31. Fawley WN, Knetsch CW, MacCannell DR, Harmanus C, Du T, Mulvey MR, et al. Development and Validation of an Internationally-Standardized, High-Resolution Capillary Gel- Based Electrophoresis PCR-Ribotyping Protocol for Clostridium difficile. PLoSOne. 2015;10(2):e0118150. DOI: 10.1371/journal.pone.0118150 [doi]; PONE-D-14-35721 [pii]. PMID: 25679978
32. Gürtler V. Predicting genome variations between passages of Clostridium difficle by ribotypes. Microbiol Aust. 2015;36(3):109-10.. Available from: http://microbiology.publish.csiro.au/?act=view_fileandfile_id=MA15038.pdf. DOI:10.1071/MA15038
33. Drewe JA, Hoinville LJ, Cook AJ, Floyd T, Stark KD. Evaluation of animal and public health surveillance systems: a systematic review. Epidemiol Infect. 2012;140(4):575-90. S0950268811002160 [pii]; DOI: 10.1017/S0950268811002160 [doi]. PMID: 22074638
34. European Centre for Disease Prevention and Control (ECDC). Minutes of the 39th meeting of the Advisory Forum, Stockholm, 24-25 September 2014. Stockholm: ECDC; 2014. Available from: http://ecdc.europa.eu/en/aboutus/governance/af/AF%20%20Meeting%20Minutes/Advisory-Forum-minutesmeeting-39.pdf